Clinical Effects of Pacifier Use in Preterm During Orogastric Tube Feeding

September 6, 2022 updated by: Yeliz Taşdelen, Zonguldak Bulent Ecevit University
The purpose of the study was to assess how preterm babies' vital signs, feeding time, and gastric residual volume were affected by using a pacifier only or a pacifier with breast milk during orogastric tube feeding.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kozlu
      • Zonguldak, Kozlu, Turkey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 months to 9 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Feeding with the orogastric tube
  • Breastmilk along with formula (babies who receive more than 50% of their total feed in 24 hours from formula)
  • Gestation week between 29+0 weeks and 34+0 weeks
  • Weight of 1000 g or more

Exclusion Criteria:

  • Receiving mechanical ventilator support
  • Development of sepsis
  • Presence of neurological disease
  • Presence of chromosomal or congenital anomalies
  • Presence of intraventricular bleeding
  • Unstable physiological parameters
  • No breast milk

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Pacifier only
Participants in the pacifier-only group will get a pacifier five minutes prior to tube feeding. During feedings, a pacifier will be employed. Five minutes following the end of tube feeding, the pacifier application will be discontinued. The vital signs will be monitored prior to, during, and following feeding. Two hours after the feeding has finished, the volume of gastric residue will be controlled.
Pacifiers produced for premature babies will be used in the study. Pacifiers will be made of silicone material suitable for premature baby health and will not contain any harmful substances. A separate pacifier will be used for each baby, and pacifiers will be sterilized before use.
Other: Pacifier with breast milk
Five minutes prior to tube feeding, participants in the pacifier with breast milk group will get their own breast milk dripping pacifier. During feedings, a pacifier will be employed. Five minutes following the end of tube feeding, the pacifier application will be discontinued. The vital signs will be monitored prior to, during, and following feeding. Two hours after the feeding has finished, the amount of gastric residue will be controlled.
Pacifiers produced for premature babies will be used in the study. Pacifiers will be made of silicone material suitable for premature baby health and will not contain any harmful substances. A separate pacifier will be used for each baby, and pacifiers will be sterilized before use.
For babies assigned to the pacifier with breast milk group, their own breast milk will be applied by dripping 1 ml into the pacifier.
No Intervention: standard care (no pacifier)
The premature babies in the standard care (no pacifier) will get standard care while being fed through an orogastric tube. The vital signs will be monitored prior to, during, and following feeding. Two hours after the feeding has finished, the amount of gastric residue will be controlled.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Heart rate will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Respiratory rate change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Respiratory rate will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Saturation level change
Time Frame: 5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Saturation level will be measured 5 minutes before tube feeding, during tube feeding and 5 minutes after the end of tube feeding.
5 minutes before tube feeding, during tube feeding and 5 minutes after tube feeding
Feeding duration
Time Frame: measured with a stopwatch for 7 months.
Each baby's tube feeding duration will be measured.
measured with a stopwatch for 7 months.
Gastric residual volume
Time Frame: Gastric residue will be measured 2 hours after the end of infant feeding.
Gastric residue will be measured 2 hours after the end of infant feeding.
Gastric residue will be measured 2 hours after the end of infant feeding.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

March 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

August 29, 2022

First Submitted That Met QC Criteria

September 6, 2022

First Posted (Actual)

September 7, 2022

Study Record Updates

Last Update Posted (Actual)

September 7, 2022

Last Update Submitted That Met QC Criteria

September 6, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BEU-YTASDELEN-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature

Clinical Trials on Pacifier

3
Subscribe